Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1319 of 5804
-
New stomach drug may protect heart patients from dangerous bleeding
Prevention Recruiting nowThis study evaluates whether fexuprazan is effective in preventing upper gastrointestinal bleeding and related upper gastrointestinal clinical events in high bleeding risk patients who require dual antiplatelet therapy after coronary stent implantation. A total of 400 participan…
Phase: NA • Sponsor: SUK MIN SEO • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC
-
New hope for myelofibrosis patients: experimental pill targets resistant disease
Disease control Recruiting nowAJX-101 is a first-in-human (FIH), phase 1, non-randomized, multi-center, open-label clinical trial designed to investigate the safety, tolerability, pharmacokinetics (PK), clinical activity and changes in biomarkers of an orally administered type II JAK2 inhibitor, AJ1-11095, in…
Phase: PHASE1 • Sponsor: Ajax Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
AI may speed up heart procedure for dangerous rhythm disorder
Disease control Recruiting nowOver the last decade, radiofrequency catheter ablation (RFCA) has become an established treatment for ventricular arrhythmias (VA). Due to the challenging nature of visualizing lesion formation in real time and ensuring an effective transmural lesion, different surrogate measures…
Phase: NA • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a single dose of azithromycin save more malnourished kids?
Disease control Recruiting nowAmoxicillin is recommended by the World Health Organization (WHO) as adjunctive therapy for the treatment of uncomplicated severe acute malnutrition (SAM). Because children with uncomplicated SAM may have asymptomatic infection due to immune suppression, presumptive treatment wit…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New ultrasound technique could spot cancer in lymph nodes without a needle
Diagnosis Recruiting nowLymph nodes are one of the most important components of the human immune system, and superficial lymph node enlargement lacks specificity. Ultrasound examination has been widely used in the diagnosis of lymph node lesions and is of great significance in distinguishing between be…
Sponsor: Peking University Third Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 13:47 UTC
-
Could water replace gas in colonoscopies for better polyp detection?
Disease control Recruiting nowColorectal cancer (CRC), the third most diagnosed cancer and second most common cause of cancer death. CRCs develop from precursors like adenomas (about 70% of CRCs) or serrated lesions (SSLs) (about 25-30% of CRCs). Colonoscopy is the cornerstone in CRC screening, in screening p…
Phase: NA • Sponsor: Vestre Viken Hospital Trust • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New study brings obesity treatment to kids who need it most
Disease control Recruiting nowEvidence-based obesity treatment is inaccessible to most children in the United States. This lack of access is a source of health inequity, whereby children from rural and minority communities, who have the highest rates of childhood obesity, are also the least likely to receive …
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Universal CAR-T therapy takes on advanced colorectal cancer
Disease control TerminatedThis is an investigator initiated trial to assess the efficacy and safety of a GCC-targeting CAR-T therapy (REVO-UWD-01) in the metastatic colorectal cancer. It also aims to explore the feasibility of using a novel universal CAR-T cell platform.
Phase: EARLY_PHASE1 • Sponsor: Wondercel Biotech (ShenZhen) • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Universal CAR-T therapy targets Hard-to-Treat liver and lung cancers
Disease control TerminatedThis is an investigator initiated trial to assess the efficacy and safety of a GPC3-targeting CAR-T therapy (REVO-UWD-03) in the HCC and Lung Cancer. It also aims to explore the feasibility of using a novel universal CAR-T cell platform.
Phase: EARLY_PHASE1 • Sponsor: Wondercel Biotech (ShenZhen) • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New quadrivalent flu vaccine shows promise for little ones
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to evaluate the safety and immunogenicity of IL-YANG Inactivated Split Influenza Vaccine (IL-YANG Quadrivalent Seasonal Influenza Vaccine) in healthy infants from 6 months to under 3 years of age(≥ 6 months and \< 3 years)
Phase: PHASE3 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 10, 2026 00:00 UTC
-
New pill aims to soothe Alzheimer's agitation in major trial
Symptom relief Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled, flexible-dose study of the efficacy, safety, and tolerability of ITI-1284 in patients with agitation associated with Alzheimer's dementia
Phase: PHASE2 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New drug aims to fix Chemo's side effect: low platelets
Symptom relief Recruiting nowTo evaluate the efficacy and safety of QL0911 in cancer treatment-induced thrombocytopenia. Thrombocytopenia is a low number of platelets in the blood. Sometimes, thrombocytopenia is a side effect of cancer treatment.
Phase: PHASE2, PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Surgery or more drugs? new study aims to guide tough UC decisions
Disease control Recruiting nowUlcerative colitis is an inflammatory disease affecting the rectum and colon, most commonly presenting in late adolescence or early adulthood. The primary treatment approach is pharmacological. Over the past two decades, there has been significant progress in the development of s…
Sponsor: Region Stockholm • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Gene therapy trial for advanced kidney cancer halted early
Disease control TerminatedThis is an open label, single-centre phase 1/2 study involving a single dose of Temferon, an investigational Advanced Therapy Medicinal Product (ATMP), to treat patients with metastatic clear cell renal cell carcinoma (RCC) with evidence of disease progression following at least …
Phase: PHASE1, PHASE2 • Sponsor: Genenta Science • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
VR video games could be the new treatment for lazy eye in children
Disease control Recruiting nowParticipants eligible for the study will be randomly allocated (1:1:1) to receive either Luminopia dichoptic treatment while wearing optical correction if needed, Vivid Vision dichoptic treatment while wearing optical correction if needed, or continued optical correction alone if…
Phase: PHASE3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New device aims to quiet overactive bladder in men
Symptom relief Recruiting nowTo assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
Phase: NA • Sponsor: Axonics, Inc. • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
JARDIANCE® under the microscope: can it safely protect kidneys Long-Term?
Disease control OngoingStudy objective is to investigate the safety and effectiveness of long-term daily use of JARDIANCE® Tablets in patients with chronic kidney disease under real-world use.
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug cocktail aims to shrink prostate tumors before surgery
Disease control Recruiting nowThe goal of this clinical trial is to determine the safety and feasibility of a new combination of darolutamide and relugolix as neoadjuvant therapy preceding radical prostatectomy (RP) for high-risk prostate cancer (PCa) in adult males.
Phase: PHASE1 • Sponsor: AdventHealth • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Classroom lights and phone apps aim to stop Kids' Short-Sightedness
Prevention Recruiting nowThe goal of this clinical trial is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. The trial also aims to better understand the impact of light exposure on sleep and cognitive performance…
Phase: NA • Sponsor: National University of Singapore • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
New drug aims to calm overactive immune system in rare disorders
Disease control OngoingThis study is an exploratory, non-randomized, open-label, within-patient dose escalation study. The primary objective is to assess safety and tolerability of leniolisib. Secondary objectives include assessments of PK/PD, and to explore clinical efficacy measures with administrati…
Phase: PHASE2 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC